Skip to main content


Weitere Artikel dieser Ausgabe durch Wischen aufrufen

01.11.2013 | original article | Ausgabe 21-22/2013

Wiener klinische Wochenschrift 21-22/2013

Differences in the metabolic status of healthy adults with and without active brown adipose tissue

Wiener klinische Wochenschrift > Ausgabe 21-22/2013
Qiongyue Zhang, Hongying Ye, Qing Miao, Zhaoyun Zhang, Yi Wang, Xiaoming Zhu, Shuo Zhang, Chuantao Zuo, Zhengwei Zhang, Zhemin Huang, Ruidan Xue, Meifang Zeng, Haiyan Huang, Wanzhu Jin, Qiqun Tang, Yihui Guan, Yiming Li
Wichtige Hinweise
An erratum to this article can be found at http://​dx.​doi.​org/​10.​1007/​s00508-014-0532-6.



Previous studies have proven the existence of active brown adipose tissue (BAT) in adults; however, its effect on systematic metabolism remains unclear.


The current study was designed to investigate the differences in the metabolic profiles of healthy adults with and without active BAT using positron emission tomography–computed tomography (PET-CT) scans in the un-stimulated state.


A cross-sectional analysis was performed to assess the health of adults using PET-CT whole-body scans at Huashan Hospital Medical Centre between November 2009 and May 2010. A total of 62 healthy adults with active BAT were enrolled in the BAT-positive group. For each positive subject, a same-gender individual who underwent PET-CT the same day and who had no detectable BAT was chosen as the negative control. Body composition was measured, and blood samples were collected for assays of metabolic profiles and other biomarkers.


In both the male and female groups, BAT-positive individuals were younger and had lower body mass indexes, fasting insulin, insulin resistance, and leptin, but a greater level of high-density lipoprotein cholesterol compared with the negative controls. In the male group, body fat content and levels of tumor necrosis factor-α were significantly lower in the BAT-positive than in the negative control group.


The healthy adults with active BAT in an un-stimulated state had favorable metabolic profiles suggesting that active BAT may be a potential target for preventing and treating obesity and other metabolic disorders.

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Sie möchten Zugang zu diesem Inhalt erhalten? Dann informieren Sie sich jetzt über unsere Produkte:

Abo für kostenpflichtige Inhalte

Über diesen Artikel

Weitere Artikel der Ausgabe 21-22/2013

Wiener klinische Wochenschrift 21-22/2013 Zur Ausgabe

mitteilungen der gesellschaft

Die Österreichische Apheresegesellschaft

mitteilungen der gesellschaft der ärzte in wien

mitteilungen der gesellschaft der ärzte in wien